Sunday, November 18, 2012

• 2 Biopharmaceutical Stocks with Strong Net Cashat Motley Fool (Sun, Nov 18)

Wednesday, November 14, 2012

• Palatin Investors Prepared For The Long Haul With Another FSD Drugat Seeking Alpha (Wed, Nov 14)
• Improving Trend in FDA First Cycle Review Approvals a Major Factor for Biotech Industry's Success in 2012Marketwired (Wed, Nov 14)

Thursday, November 8, 2012

• BIOSANTE PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly ReportEDGAR Online (Thu, Nov 8)
• BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Results of Operations and Financial Condition, Other Events, FinanciEDGAR Online (Thu, Nov 8)
• BioSante Pharmaceuticals Reports Third Quarter Financial Results and Merger UpdateBusiness Wire (Thu, Nov 8)

Wednesday, October 17, 2012

• Multiple Catalysts Ahead For Depomedat Seeking Alpha (Wed, Oct 17)

Monday, October 15, 2012

• FDA Considering Faster Pathway for Treatments of Deadly or Debilitating DiseasesMarketwired (Mon, Oct 15)

Monday, October 8, 2012

• Can a Reverse Split Reverse the Trend?at Motley Fool (Mon, Oct 8)

Friday, October 5, 2012

• Healthcare Business Report: Pfizer’s Top Line Data, BioSante Merges With ANIat Wall St. Cheat Sheet (Fri, Oct 5)
• Merger and Acquisitions Review: Unilever Shops Skippy, Microsoft Buys PhoneFactorat Wall St. Cheat Sheet (Fri, Oct 5)

Thursday, October 4, 2012

• BioSante Waves the White Flagat Motley Fool (Thu, Oct 4)
• BioSante Pharmaceuticals merges with ANI Pharm in $95 million dealat bizjournals.com (Thu, Oct 4)
• Female Viagra Maker BioSante to Be Taken Over by Private Equity-Backed Companyat Minyanville (Thu, Oct 4)
• BioSante will merge with ANI Pharma in stock dealAP (Thu, Oct 4)
• 3 Questions for Roaring Reprosat Motley Fool (Thu, Oct 4)
• BIOSANTE PHARMACEUTICALS INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Regulation FD DisclosureEDGAR Online (Thu, Oct 4)

Monday, October 1, 2012

• Biotech Industry Looks to Benefit From New Act Designed to Promote R&D Joint VenturesMarketwired (Mon, Oct 1)

Tuesday, September 25, 2012

• 4 Biotech Stocks Under $10 Soaring Higherat TheStreet (Tue, Sep 25)

Thursday, September 20, 2012

• 3 Ways To Trade Biotechnology Stocksat Seeking Alpha (Thu, Sep 20)
• Repros Therapeutics Gets Things Shakingat Motley Fool (Thu, Sep 20)
• Under Construction Rehash: Buy Acadia And Astexat Seeking Alpha (Thu, Sep 20)

Tuesday, September 18, 2012

• Wall Street Transcript Interview with Cyclacel Pharmaceuticals, Inc. (CYCC) President and Chief Executive Officer Spiro RombotisWall Street Transcript (Tue, Sep 18)

Friday, September 14, 2012

• Top Biotechnology Stock Picks from Oppenheimer & Company Research AnalystWall Street Transcript (Fri, Sep 14)

Wednesday, September 12, 2012

• 3 Vaccine Companies With Upcoming Catalysts - Part IIat Seeking Alpha (Wed, Sep 12)

Add BPAX News to My Yahoo!